Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00003175
What this trial is testing

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Medical Research Council 45
Not applicableStudy completedNCT00539773
What this trial is testing

Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder

Who this might be right for
Transitional Carcinoma of Urinary Bladder
King Faisal Specialist Hospital & Research Center 10
Testing effectiveness (Phase 2)Study completedNCT00310011
What this trial is testing

Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Wake Forest University Health Sciences 71
Testing effectiveness (Phase 2)UnknownNCT05912205
What this trial is testing

Disitamab Vedotin Combined With Radiotherapy for Bladder Preservation

Who this might be right for
Urothelial Carcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 30
Not applicableEnded earlyNCT01495676
What this trial is testing

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer

Who this might be right for
Infiltrating Bladder Urothelial Carcinoma
Institut du Cancer de Montpellier - Val d'Aurelle 69
Testing effectiveness (Phase 2)Study completedNCT00526656
What this trial is testing

Sunitinib in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder Cancer
Case Comprehensive Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT03945162
What this trial is testing

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

Who this might be right for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Theralase® Technologies Inc. 90
Testing effectiveness (Phase 2)Ended earlyNCT00363883
What this trial is testing

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Who this might be right for
Localized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+2 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)Study completedNCT00047216
What this trial is testing

Tipifarnib in Treating Patients With Recurrent Bladder Cancer

Who this might be right for
Bladder Cancer
University Health Network, Toronto
Testing effectiveness (Phase 2)Active Not RecruitingNCT05327530
What this trial is testing

The Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)

Who this might be right for
Locally Advanced or Metastatic Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc. 256
Testing effectiveness (Phase 2)Ended earlyNCT00089128
What this trial is testing

Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer

Who this might be right for
Bladder Cancer
Medical University of South Carolina 16
Testing effectiveness (Phase 2)Ended earlyNCT00859339
What this trial is testing

Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCC

Who this might be right for
Transitional Cell Carcinoma of the Bladder
Noah Hahn, M.D. 9
Testing effectiveness (Phase 2)Study completedNCT00578526
What this trial is testing

SU011248 for Platinum-Refractory Urothelial Cancer Evaluation Trial

Who this might be right for
Urothelial CancerBladder CancerAdult
AHS Cancer Control Alberta 64
Testing effectiveness (Phase 2)Ended earlyNCT01663285
What this trial is testing

Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC)

Who this might be right for
Urothelial CancerBladder Cancer
University of Michigan Rogel Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT00805129
What this trial is testing

Everolimus (RAD001) in Metastatic Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Bladder CancerMetastatic Transitional Cell Carcinoma
Memorial Sloan Kettering Cancer Center 46
Testing effectiveness (Phase 2)Study completedNCT02015104
What this trial is testing

Study of Bacillus Calmette-Guerin (BCG) Combined With PANVAC Versus BCG Alone in Adults With High Grade Non-Muscle Invasive Bladder Cancer Who Failed At Least 1 Course of BCG

Who this might be right for
Bladder Cancer
National Cancer Institute (NCI) 32
Large-scale testing (Phase 3)Study completedNCT00389155
What this trial is testing

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Who this might be right for
Bladder CancerTransitional Cell CarcinomaMetastasis
Bristol-Myers Squibb 34
Testing effectiveness (Phase 2)WithdrawnNCT01639521
What this trial is testing

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Who this might be right for
Anterior Urethral CancerLocalized Transitional Cell Cancer of the Renal Pelvis and UreterPosterior Urethral Cancer+7 more
University of Southern California
Large-scale testing (Phase 3)Study completedNCT00033436
What this trial is testing

Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
Mount Vernon Cancer Centre at Mount Vernon Hospital 330
Next Page